Pharma Redx is latest firm to delist from AIM Redx chair Dr Jane Griffiths said: “We believe our current market valuation is not reflective of our track record or future potential” Evening Standard · Apr 2, 2024
'Everywhere I look private companies are more valuable': Biotech firm C4X becomes latest to quit London stock market Biotech firm C4X today became the latest business to abandon the London stock market after is said its future growth would be better secured through private investment. Evening Standard · Mar 27, 2024